Esperion Therapeutics (ESPR) Accumulated Depreciation & Amortization: 2018-2024
- Esperion Therapeutics' Accumulated Depreciation & Amortization was N/A to $2.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.2 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is N/A change from last year.
- According to the latest figures from Q4 2024, Esperion Therapeutics' Accumulated Depreciation & Amortization is $2.1 million, which was down 18.70% from $2.6 million recorded in Q4 2022.
- Esperion Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $2.6 million for Q4 2022, and its period low was $1.6 million during Q4 2020.
- Moreover, its 2-year median value for Accumulated Depreciation & Amortization was $2.3 million (2022), whereas its average is $2.3 million.
- Data for Esperion Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY spiked of 52.38% (in 2020) over the last 5 years.
- Esperion Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $1.6 million in 2020, then surged by 30.55% to $2.1 million in 2021, then grew by 24.38% to $2.6 million in 2022, then reached $2.1 million in 2024.
- Its last three reported values are $2.1 million in Q4 2024, $2.6 million for Q4 2022, and $2.1 million during Q4 2021.
